NCT04297748 2023-01-17Bioimaging Study of 89Zr-M7824 in NSCLCOlivia Newton-John Cancer Research InstitutePhase 1/2 Terminated5 enrolled
NCT04158700 2020-02-19A Study of LY3200882 and Pembrolizumab in Participants With Advanced CancerEli Lilly and CompanyPhase 1/2 Withdrawn